BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 8105410)

  • 1. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 and D2 receptors and circling behavior in rats with unilateral lesion of the entopeduncular nucleus.
    Pazo JH; Murer GM; Segal E
    Brain Res Bull; 1993; 30(5-6):635-9. PubMed ID: 8096164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite influences of dopaminergic receptor subtypes on penile erection.
    Zarrindast MR; Shokravi S; Samini M
    Gen Pharmacol; 1992 Jul; 23(4):671-5. PubMed ID: 1356874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.
    Borowsky B; Kuhn CM
    Neuropharmacology; 1992 Jul; 31(7):671-8. PubMed ID: 1328919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G; LeDuc PA; Whishaw IQ
    Behav Brain Res; 1993 Jun; 55(2):253-67. PubMed ID: 8102851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H; Gerlach J; Peacock L
    Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
    Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
    Imperato A; Obinu MC; Gessa GL
    Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.